These results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 support the strategy of concentrating on ACKR3 as a novel approach to modulate the opioid technique, which could open new therapeutic avenues for opioid-related disorders. Importantly, these receptors were uncovered https://juliap616txz2.aboutyoublog.com/profile